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Objective: To explore: (i) cardiovascular disease risk factors 
and the 10-year clustered risk of a fatal cardiovascular event 
in adults with spastic bilateral cerebral palsy; and (ii) re-
lationships between the 10-year risk and body fat, aerobic 
fitness and physical activity. 
Design: Cross-sectional study.
Subjects: Forty-three adults with spastic bilateral cerebral 
palsy without severe cognitive impairment (mean age 36.6 
years (standard deviation 6); 27 men). 
Methods: Biological and lifestyle-related risk factors and 
the 10-year risk according to the Systematic Coronary Risk 
Evaluation (SCORE) were assessed. Relationships were 
studied using multivariable linear regression analysis.
Results: The following single risk factors were present: hy-
pertension (n = 12), elevated total cholesterol (n = 3), low 
high-density lipoprotein cholesterol (n = 5; all men), high-
risk waist circumference (n = 11), obesity (body mass index; 
n = 5; all men), reduced aerobic fitness (on average 80% of 
reference values), reduced level of everyday physical activity 
(on average 78% of reference values) and smoking (n = 9). 
All participants had a 10-year risk < 1%. Corrected for gen-
der, participants with higher waist circumference (β = 0.28; 
p = 0.06) or body mass index (β = 0.25; p = 0.08) tended to 
have a higher 10-year risk. 
Conclusion: In this relatively young adult sample of people 
with spastic bilateral cerebral palsy several single cardio-
vascular disease risk factors were present. The 10-year fa-
tal cardiovascular disease risk was low, and higher body fat 
tended to be related to higher 10-year risk.
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ference; physical fitness; cerebral palsy. 
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INTRODUCTION
Cardiovascular disease (CVD) is a leading cause of morbidity 
and mortality worldwide, including in The Netherlands (1–3). 
Numerous studies of the general population have demonstrated 
that high body fat, low aerobic fitness and lack of physical 
activity are risk factors for CVD (4–6). Persons with chronic 
physical conditions, such as cerebral palsy (CP), may be at 
increased risk of developing CVD (7) because they have low 
levels of both aerobic fitness (8, 9) and everyday physical 
activity (10–13). Evidence for this hypothesis has been found 
in persons with spinal cord injury (7). 
Nowadays, well-functioning persons with CP have a survival 
outlook close to that of the general population (14, 15) and 
CVD may become of increasing concern. Strauss et al. (14) 
demonstrated that mortality due to ischaemic heart disease 
and cerebrovascular disease were elevated in persons with 
CP, whereas Hemming et al. (15) found no such association. 
Little is known about single CVD risk factors in CP. Some 
studies have been performed on body fat in adults, with con-
flicting results (16). In the USA and Korea, the number of 
ambulatory children with CP and overweight has increased 
over time (17, 18). Reduced levels of physical fitness have 
been found among children (9) and adults (8, 19) with CP. 
Low levels of everyday physical activity were demonstrated 
in children and adults with bilateral CP (11, 12), but not in 
adults with unilateral CP (20). On the other hand, Turk et al. 
(21) reported a low percentage of smoking (2%) among women 
with CP. To our knowledge comprehensive data concerning 
traditional CVD risk factors, such as blood pressure, lipid 
profile and diabetes mellitus in adults with CP, are scarce (22). 
Exploring single CVD risk factors is necessary to obtain 
insights into condition-specific problems and preventive strate-
gies. Apart from single risk factors, it is important to investigate 
clustered risk, because it estimates CVD risk better than the 
sum of separate risk factors (23). In adults with CP, there are 
no objective data about clustered CVD risk. 
The aims of the present study were to investigate biologi-
cal and lifestyle-related CVD risk factors, and to assess the 
clustered 10-year risk of a fatal cardiovascular event in adults 
with spastic bilateral cerebral palsy (SBCP), aged 25–45 years, 
without severe cognitive impairment. Furthermore, as body fat, 
aerobic fitness and everyday physical activity are modifiable 
factors from an exercise perspective, we explored associa-
tions between the 10-year risk and these factors. Because it is 
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important to explore cardiovascular risk and begin preventive 
strategies early in life, a relatively young adult sample was 
studied (3, 5).
METHODS
Study sample
Participants were recruited from 10 rehabilitation centres in The 
Netherlands, including historical paediatric registers, and via the As-
sociation of Physically Disabled Persons and their Parents (BOSK). 
The inclusion criteria were: a diagnosis of SBCP and age 25–45 years. 
Exclusion criteria were: (i) any multimorbidity with lasting effects 
on everyday physical activity or contraindicated for a progressive 
maximal ergometer test; (ii) full dependence on powered wheelchair 
propulsion; (iii) inadequate Dutch language proficiency; (iv) legal 
inability, which refers to persons who are not able to grant consent 
for participation; and (v) severe cognitive impairment according to 
medical files. This criterion excluded persons who could not under-
stand study instructions.
This study was part of a larger cross-sectional study in 56 partici-
pants on daily functioning and physical fitness (24). Prior to this larger 
study, 6 persons were excluded because of multimorbidity, including 
severe lung disease. From the original cohort of 56 participants (24), 
13 could not participate in the present study due to no consent to blood 
withdrawal (n = 12) and missing values for blood pressure (n = 1). 
Therefore, 43 adults with SBCP participated in the present study. In 
a non-response study, participants were older than non-participants 
(mean difference 2.7 years; p < 0.05), but there was no difference 
regarding gender or distribution of limb impairment. All participants 
received verbal and written information about the study and gave their 
written consent to participate. The study was approved by the medical 
ethics committee of the Erasmus Medical Center and the participating 
rehabilitation centres.
Measurements
Characteristics of study sample. Neuromotor abnormality was 
classified according to the Reference and Training Manual of the 
Surveillance of CP in Europe (SCPE) (25), and gross motor function-
ing according to the Gross Motor Function Classification System 
(GMFCS) (26). Age, gender, ethnicity, level of education, employ-
ment and civil status were reported. For each participant the medical 
and family history of hypertension, CVD and diabetes mellitus, and 
the use of antihypertensive, lipoprotein metabolism and anti-diabetic 
drugs were recorded. 
Biological risk factors. Blood pressure was measured while the par-
ticipants were seated for 10 min prior to the measurement. Using a 
sphygmomanometer (Maxi Stabil, Speidel&Keller, Jungingen, Ger-
many) and appropriately sized measure cuff, systolic blood pressure 
(SBP) and diastolic blood pressure (DBP) were measured twice and 
mean values were recorded. Blood pressure was classified according 
to the 7th report of the Joint National Committee on Prevention, Detec-
tion, Evaluation and Treatment of High Blood Pressure (JNC 7) (2). 
Total serum cholesterol (TC), high-density lipoprotein cholesterol 
(HDL-C) and glucose were measured by taking non-fasting venous 
blood samples of approximately 10 ml from the vena antecubitis with 
a vacutainer. Their concentrations were determined using routine 
methods on a Roche Modular analyser (Roche Diagnostics, Almere, 
The Netherlands). Values of lipids were categorised according to the 
National Cholesterol Education Program, Adult Treatment Panel III 
(NCEP ATP III) (27) and glucose according to well known non-fasting 
cut points (3, 28). Non-fasting samples were used, which is allowed 
for CVD risk estimation (1, 27).
As indicators of body fat, waist circumference and body mass index 
(BMI) were assessed. Waist circumference was measured midway 
between the lower rib margin and the iliac crest, with the tape posi-
tioned evenly around the bare abdomen (1, 28) while the participant 
was lying supine instead of standing. The mean waist circumference 
of 2 measurements was recorded in centimetres. Standing waist cir-
cumference was calculated from the supine waist circumference by 
the correction equation of Waninge et al. (29) and classified according 
to Lean et al. (30). BMI (kg/m2) was calculated and classified accord-
ing to the World Health Organization (WHO) criteria on BMI (1, 3). 
Height was measured while lying supine, in case of contractures from 
joint to joint. Weight was measured on a digital chair scale (Cormier, 
type H.F., France).
Aerobic fitness was measured during a progressive maximal exercise 
test on an electronically braked cycle ergometer (Jaeger ER 800, Jaeger 
Toennies, Breda, The Netherlands) by a portable breath-by-breath gas 
analyser (K
4
b2, Cosmed, Rome, Italy). Detailed descriptions of this 
test, based on the McMaster All-Out Progressive Continuous Proto-
col, can be found elsewhere (8). Aerobic fitness was operationalised 
as the mean oxygen uptake during the last 30 s of exercise (VO
2peak
, 
expressed in l/min). The cycle ergometer test was performed in 35 
participants. Eight participants were excluded because of severe hy-
pertension (n = 1), missing values (n = 2) and inability to cycle (n = 5, 
due to severe spastic paresis, impaired balance and/or osteoarthritis).
Lifestyle-related risk factors. The level of everyday physical activity 
was objectively measured during 2 consecutive weekdays using an 
accelerometry-based activity monitor (AM; Temec Instruments BV, 
Kerkrade, The Netherlands) (11, 13). The level of everyday physical 
activity was operationalised as the mean duration of dynamic activi-
ties (composite measure of the separately detected activities walking 
(including walking stairs and running), wheelchair propulsion, cy-
cling, and general non-cyclic movement) of the 2 measurement days, 
expressed in min/day. 
Smoking behaviour and alcohol consumption were assessed in a 
face-to-face interview. We recorded smoking (yes/no), and classified 
the level as heavy smoking (≥ 20 cigarettes (cig)/day) or not (28). 
Drinking alcohol was classified as never, light (1 drink/day), intermedi-
ate (> 1– <3 drinks/day) or heavy (≥ 3 drinks/day) (28). 
European Systematic Coronary Risk Evaluation (SCORE). Following 
the current European and Dutch guidelines for primary prevention of 
CVD, the individual 10-year absolute risk of a fatal atherosclerotic 
event including heart attack, stroke, or aortic aneurysm was estimated 
by using SCORE (1, 31). SCORE is a CVD risk assessment model 
based on a large data-set tested thoroughly on European data (23). It 
takes an individual’s overall risk profile into account and estimates 
the clustered 10-year CVD risk directly. The individual SCORE-risk 
was calculated for all participants according to the equation of the 
original reference (23), which includes the risk factors age, gender, TC, 
mean SBP, and cigarette smoking. The SCORE low-risk equation was 
used, which is applicable for regions with a low CVD risk in Europe, 
including The Netherlands (32).
Dutch reference samples. Blood pressure, TC, HDL-C, TC/HDL-C 
ratio, glucose, BMI, smoking and alcohol behaviour were compared 
with Dutch reference values obtained using comparable measurement 
procedures, e.g. non-fasting blood samples and similar age groups. 
From a total of 22,769 persons, different subgroups, all aged 20–49 
years, were selected according to the risk factor studied (28). Aerobic 
fitness was compared with reference values obtained from a healthy, 
untrained sample from the USA, Canada and 7 European countries 
(including The Netherlands) (33) and expressed as a percentage of 
these reference values. Everyday physical activity was compared 
with reference values of healthy age-mates from our own database 
and measured with the same AM protocol (n = 45) (11, 13), and ex-
pressed as a percentage of these reference values. Reference values 
are presented in Table II and compared with values of persons with 
SBCP in the discussion.
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Statistical analysis
Data were analysed using SPSS, version 17.0 (SPSS Inc., Chicago, 
IL, USA). All categorised results were tested by χ2 tests. Subgroup 
analyses were performed with the t-test for independent samples 
(gender) or with one-way analysis of variance for means and the χ2 
test for proportions (GMFCS level in 3 subgroups: I, II and III/IV). In 
case of skewed variables the Mann-Whitney U test or Kruskal-Wallis 
test were used. In Tables II and III the results are presented for gender, 
but not for GMFCS level, because the latter showed significant dif-
ferences for only 2 risk factors. p-values below 0.05 were considered 
statistically significant. 
Linear regression analysis was used to study associations. SCORE, 
waist circumference, BMI, aerobic fitness and level of everyday physi-
cal activity were treated as continuous variables. GMFCS level was 
treated a categorical variable and dichotomized in subgroups I/II and 
III/IV. Multivariable linear regression analyses were performed for 
exploring associations with SCORE low-risk (dependent variable). 
Separate regression analyses were conducted for each of the following 
independent variables, one at a time and corrected for gender (1, 23): 
GMFCS level, and the risk factors waist circumference, BMI, aerobic 
fitness or everyday physical activity, which are not included in SCORE. 
Similarly, multivariable linear regression analyses were conducted, 
with SBP or DBP as dependent variables, and waist circumference, 
BMI, aerobic fitness or everyday physical activity as independent 
variables, corrected for gender. 
To compare the influence of variables with a different scale, stand-
ardised regression coefficients (Beta, β) were calculated, expressing 
the influence of a shift of 1 SD of the variables on the outcome of 
interest. Beta, confidence intervals (95% CI) and explained variance 
(R2; %) are reported. 
RESULTS
Characteristics and medical history of the study sample 
Characteristics of the study sample are presented in Table I. 
None of the adults with SBCP had a medical history of CVD 
or diabetes mellitus. Two adults had a medical history of hy-
pertension, both of whom used antihypertensive drugs prior to 
the study. No participants used lipoprotein metabolism drugs. 
The family medical history was known for 39 participants, of 
whom 6 participants had positive kindreds (6 CVD, 2 diabetes 
mellitus).
Biological and lifestyle-related risk factors for CVD
Descriptive results of single biological and lifestyle-related risk 
factors for the participants with SBCP and the Dutch reference 
samples are shown in Table II. According to classifications 
of CVD risk factors (2, 3, 27) (Table III), several risk factors 
were present in some of the participants: hypertension (n = 11); 
elevated levels of TC (n = 3); and high waist circumference 
(n = 11). Risk factors present only in men with SBCP were: low 
HDL-C (n = 5), representing a major risk; and obesity based on 
BMI (n = 5). All adults with SBCP had normal blood glucose 
levels. Levels of aerobic fitness (mean 79.7% (SD 12.8) 
of reference values) and everyday physical activity (mean 
78.4% (SD 35.9) of reference values) were both reduced in 
the participants. 
Subgroup analyses showed a significant difference between 
men and women with SBCP for waist circumference based 
on categories (p = 0.02) (Table III). In addition to obesity, 
underweight was present only in men (Tables II and III). 
Women with SBCP had significantly more favourable scores 
for DBP, HDL-C, TC/HDL-C ratio and VO
2peak
 (expressed as 
a percentage of reference values) than men with SBCP (Table 
II). For GMFCS level, 2 differences were found: more study 
participants in GMFCS level II than in levels I and III/IV had 
hypertension (p < 0.001), and a lower level of everyday physi-
cal activity was noted in participants with GMFCS level III/
IV (82.0 min/day (SD 43.8)) than with GMFCS level I (148.7 
min/day (SD 41.3) (p = 0.009). 
Ten-year risk, blood pressure and associations with body fat, 
aerobic fitness and everyday physical activity 
All adults with SBCP had a SCORE risk of < 1%, which 
equates to a low 10-year risk of fatal CVD (Table II). The risk 
for women was lower than for men (p = 0.001). Corrected for 
gender, participants with a higher waist circumference tended 
to be more likely to have a higher 10-year risk (β = 0.28, 
p = 0.06) (Table IV). Using BMI in the multivariable analysis 
gave comparable results (β = 0.25, p = 0.08). No associations 
were demonstrated between VO
2peak 
or everyday physical activ-
ity and 10-year risk. 
Considering the high proportion of participants with (pre)
hypertensive values (Table III), we explored modifiable fac-
tors associated with blood pressure (2) by multivariable linear 
regression analyses. Mean DBP, but not mean SBP, was as-
Table I. Characteristics of the study sample with spastic bilateral cerebral 
palsy (n = 43)
Characteristics
Age, years, mean (SD) 36.6 (6)
Gender: men, n 27
Ethnicity: Caucasian, n 43
Limb distribution, n 
Diplegia 23
Quadriplegia 20
GMFCS, n 
Level I 11
Level II 22
Level III 8
Level IV 2
Level V 0
Level of educationa, n
High 15
Medium 18
Low 10
Student/employment status, n 
Student 2
Competitively employed 25
Sheltered employed 4
Disability pension, including volunteer work 12
Civil status, n 
Married/living together 9
Single 34
aLevels of education: Low: no education or elementary school and 
pre-vocational practical education; Medium: pre-vocational theoretical 
education and upper secondary vocational education (vocational high 
school); High: secondary education, higher education and university.
SD: standard deviation.
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sociated with waist circumference (β = 0.34, p = 0.03) and BMI 
(β = 0.36, p = 0.02) after correcting for gender. No associations 
were demonstrated with aerobic fitness (SBP: β = 0.15, p = 0.51; 
DBP: β = 0.27, p = 0.21) or everyday physical activity (SBP: 
β = 0.02, p = 0.91; DBP: β = 0.001, p = 0.10).
DISCUSSION
This sample of adults with SBCP without severe cognitive im-
pairment, aged 25–45 years, had a 10-year fatal cardiovascular 
risk of < 1%. Although this is a low 10-year risk, several single 
biological and lifestyle-related risk factors were present in the 
relatively young study sample. 
In total, 12 (28%) participants had hypertension, including 
one person with a medical history of hypertension, who used 
antihypertensive drugs prior to our study, resulting in prehyper-
tensive values. Prehypertensive values were found in another 
44% of the participants, which makes them at increased risk for 
progression to hypertension (2). The study sample had a higher 
blood pressure than a Dutch reference sample (28), including 
a two-fold higher hypertension rate in men with SBCP. The 
high proportion of participants with (pre)hypertensive values 
underlines the importance of regularly measuring and manag-
ing blood pressure from young adulthood onwards. 
Obesity according to BMI was reported more often in men 
with SBCP than in men in the reference group. A high waist 
circumference was present in 26% of the participants. The 
adults with SBCP had reduced levels of both aerobic fitness 
and everyday physical activity (expressed as a percentage 
of reference values). These findings suggest the importance 
of controlling the risk factors body fat, aerobic fitness and 
physical activity in individuals with SBCP. In contrast to the 
aforementioned, all adults with SBCP had normal levels of 
glucose. Furthermore, in comparison with the Dutch reference 
sample (28), the lipid profile was more favourable in the study 
sample. Considering the level of underweight, dietary factors 
might play a role in this finding. In addition, less smoking and 
alcohol consumption were reported in adults with SBCP than in 
the reference group. Alcohol use among the adults with SBCP 
was light or intermediate, not heavy. Therefore an increased 
risk of CVD based on alcohol consumption is unlikely. 
Corrected for gender, participants with a higher waist 
circumference or BMI tended to have a higher 10-year fatal 
CVD risk. This trend is in line with results of other studies on 
Table II. Biological and lifestyle-related risk factors of cardiovascular disease and 10-year fatal cardiovascular disease risk in adults with spastic 
bilateral cerebral palsy and Dutch reference samples
 
 
Adults with CP (n = 43) Men vs women 
with CP
p-value
Reference sample (n = a)
Men (n = 27) Women (n = 16) Men (n = a) Women (n = a)
Biological risk factors
Blood pressure
Systolic, mmHg, mean (SD) 126 (10) 126 (10) 0.98 122 113
Diastolic, mmHg, mean (SD) 86 (11) 81 (6) 0.03 77 73
Hypertension, Systolic ≥ 140, Diastolic ≥ 90, mmHg, n, % 8 (30) 3 (19) 0.50 15 8
Blood lipid and lipoproteins, mean (SD)
Total cholesterol, mmol/l 4.7 (0.8) 5.0 (0.9) 0.18 5.0 4.9
High-density lipoprotein, mmol/l 1.3 (0.4) 1.8 (0.5) < 0.01 1.2 1.5
Total cholesterol/HDL ratio 3.8 (1.4) 2.9 (0.8) 0.005 4.6 3.5
Glucose, mmol/l, mean (SD) 4.1 (0.8) 4.7 (1.1) 0.06 5.2 5.0
Body fat, mean (SD)
Waist circumference, cm 87.8 (16.2) 80.9 (9.9) 0.09 NA NA
Body mass index, kg/m2 24.3 (6.0) 23.5 (3.0) 0.60 24.7 24
BMI ≥ 30, % 5 (18.5) 0 (0) 0.07 7.2 8
Aerobic fitness, n = 35b 
VO
2peak
, l/min, mean (SD) 2.4 (0.4) 1.7 (0.3) < 0.01 3.1 (0.14) 2.0 (0.14)
VO
2peak
 as percentage of reference valuesc, % 76.1 (11.5) 86.5 (12.8) 0.02
Lifestyle-related risk factors
Physical activity, min/day, mean (SD) 108.6 (49.3) 127.0 (59.4) 0.28 135.5 (46.1)d 175.0 (46.9)d 
Physical activity as percentage of reference values, % 81.9 (37.2) 72.6 (34.0) 0.42
Current smoker, yes, n, % 7 (26) 2 (13) 0.30 39 39
Smoking behaviour, ≥ 20 cig/day 1 (4) 0 (0) 0.44 36 32
Alcohol drinking never, n, % 11 (41) 11 (69) 0.08 9 18
Alcohol light drinking, 1 drink/day, n, % 12 (44) 4 (25) 0.20 35 57
Alcohol intermediate drinking, > 1–< 3 drinks/day, n, % 4 (15) 1 (6) 0.4 37 21
Alcohol heavy drinking ≥ 3 drinks/day, n, % 0 (0) 0 (0) NA 19 4
Clustered 10-year fatal CVD risk 
SCORE risk, %, mean (SD) 0.19 (0.18) 0.06 (0.06) 0.001 NA NA
aFrom a total of n = 22,769 persons of the Dutch general population, subgroups (aged 20–49 years) were selected according to the risk factor studied (28).
bAerobic fitness was measured in 35 participants.
cAccording to Shvartz & Rebold (33).
dAble-bodied age mates (n = 45, age ± 5 years) measured with the same activity monitor protocol (11, 13).
NA: not available; SD: standard deviation; BMI: body mass index; CVD: cardiovascular disease risk; SCORE: Systematic Coronary Risk Evaluation.
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body fat and CVD risk in the general population (1, 5, 6). We 
found no evidence for associations between aerobic fitness or 
everyday physical activity and 10-year risk. This absence of 
associations might be due to the relatively young age of the 
study sample and attendant low 10-year risk. Other possible 
explanations for the lack of associations are the relatively small 
sample size and the rather mildly affected sample (mainly 
GMFCS I and II, partly due to exclusion of persons depend-
ent on powered wheelchair propulsion or unable to perform 
cycle ergometry). Inclusion of more severely affected persons 
might have produced broader ranges of aerobic fitness and/or 
everyday physical activity, as well as possible associations 
with the 10-year CVD risk. Finally, aerobic fitness and every-
day physical activity could also influence CVD risk through 
indirect effects not covered by SCORE, in view of the known 
interrelationships among CVD risk factors (2, 4, 5). Similar 
arguments might play a role in the lack of associations between 
blood pressure and aerobic fitness or everyday physical activity. 
The association demonstrated between diastolic blood pressure 
and waist circumference suggests a contribution of abdominal 
obesity in developing high blood pressure in CP. Other factors 
in CP that might contribute to an increased risk of hypertension 
and CVD are muscle atrophy and intramuscular adiposity (7, 
22). The presence of these factors from an early age onwards 
may lead to metabolic dysregulation (endocrine disturbances, 
such as insulin resistance) and low-grade inflammation similar 
to general populations (7). Considering this, an earlier onset of 
atherosclerotic vascular disease in CP might be hypothesized. 
However, a recent study between a small sample of ambula-
tory youth with CP with low levels of physical activity and 
a healthy reference sample demonstrated no differences in 
arterial health (34). To our knowledge, arterial structure and 
function has not been studied in adults with CP. The higher 
proportion of hypertensive values demonstrated in GMFCS 
level II is probably a coincidence, as this category contains 
the largest number of study participants.
In a meta-analysis of general populations, Williams (35) 
reported that aerobic fitness and physical activity have sig-
nificantly different relationships to CVD. The reductions in 
relative risk were nearly twice as great for aerobic fitness as 
for physical activity. In more recent studies of general popula-
tions, aerobic fitness (36) but not everyday physical activity (5) 
was predictive for a healthy CVD risk profile later in life. For 
instance, in a Dutch study by Twisk et al. (5), aerobic fitness 
during adolescence was related to a healthy CVD risk profile 
at the age of 32 years, whereas everyday physical activity was 
not. However, it should be noted that methodological aspects 
(e.g. using questionnaires to assess everyday physical activity) 
might have influenced the above findings. 
Study limitations
The studied sample was relatively small. A larger sample would 
give a more precise estimate of CVD risk. However, we put 
maximal effort into attaining a representative sample, e.g. by 
extensive recruitment among a broad population. Gender, level 
of education, and GMFCS level were comparable to adults with 
Table III. Categorised cardiovascular disease risk factors in adults with 
spastic bilateral cerebral palsy (n = 43) 
  
Men 
(n = 27)
n 
Women 
(n = 16)
n p-value
Blood pressure: systolic/diastolic, mmHga 
Normative < 120/80 7 5 0.31
Prehypertension 120–139/80–89 12 8
Stage I hypertension 140–159/90–99 3 3
Stage II hypertension ≥ 160/100 5 0
Total cholesterol, mmol/lb 
Desirable < 5.2 19 10 0.55
Borderline high 5.2–6.2 7 4
High ≥ 6.2 1 2
High-density lipoprotein, mmol/lb 
High (no risk) ≥ 1.56 7 10 0.03
In between 1.04–1.55 15 6
Low (major risk) < 1.04 5 0
Glucose, mmol/l
Normal < 7.8 27 16 NA
Impaired > 7.8 –<1 1.0 0 0
Indication diabetes mellitus >11.0 0 0
Waist circumference, cmc 
Underweight: women: < 68, men: < 79 10 0 0.02
Normal: women: ≥ 68–<  80, men: ≥ 79 –< 94 5 8
Increased: women:> 80–< 88, 
men: > 94–< 102
6 3
High-risk: women: ≥ 88, men: ≥ 102 6 5
Body mass index, kg/m2d
Underweight < 18.5 4 0 0.07
Normal ≥ 18.5 –24.9 13 13
Overweight ≥ 25.0–29.9 5 3
Obese ≥ 30.0 5 0
aAccording to the seventh report of the Joint National Committee on 
Prevention, Detection, Evaluation and Treatment of High Blood Pressure 
(2).
bAccording to the ATP III definitions of the third report of the National 
Cholesterol Education Program (27). 
cAccording to the classification of Lean et al. (30).
dAccording to World Health Organization (WHO) criteria (1, 3).
NA: not available. 
Table IV. Multivariable analysis among adults with spastic bilateral 
cerebral palsy (n = 43): relationships between 10-year cardiovascular 
disease (CVD) risk (Systematic Coronary Risk Evaluation (SCORE), 
dependent variable) and 1 independent variable (Gross Motor Function 
Classification System (GMFCS)), body fat, aerobic fitness or everyday 
physical activity) corrected for gender
Independent variables n = 43 Beta
Multivariable analysis 
95% CI R2 (%)
Gender –0.42 –0.71 to –0.14 17.6
GMFCS 0.01 –0.26 to 0.29
Gender –0.34 –0.62 to –0.06 24.5
Waist circumference, cm 0.28 –0.01 to 0.56
Gender –0.40 –0.67 to –0.13 23.8
BMI, kg/m2 0.25 –0.02 to 0.52
Gender –0.47 –0.87 to –0.07 21.1
VO
2peak
, l/min, n = 35 –0.01 –0.40 to 0.37
Gender –0.41 –0.69 to –0.13 17.8
Physical activity, min –0.05 –0.33 to 0.23
Beta: standardised regression coefficient; CI: confidence interval; R2: 
represents explained variance.
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SBCP without severe cognitive impairment in a representative 
cohort from the same geographical region (37).
Some caution is needed in interpreting the measurements. 
First, non-fasting blood samples were used for practical rea-
sons, which may lead to an overestimation of the CVD risk. 
However, the levels of TC and HDL-C are minimally altered 
when measured in fasting or non-fasting blood (38). Further-
more, there is growing evidence that HDL-C and TC/HDL-C 
ratio predict CVD when measured under non-fasting conditions 
(38, 39). For the associations of fasting or non-fasting TC 
with CVD conflicting results were found (38, 39). The Dutch 
guidelines on cardiovascular risk management recommend 
measurement of a fasting lipid profile and glucose, but allow 
non-fasting values for the estimation of CVD risk, including 
screening of the glucose level (1). The SCORE steering com-
mittee of the European Society of Cardiology and the NCEP 
guidelines (27) allow measurement of non-fasting TC and 
HDL-C as well. Thus, for the purpose of our study (estimation 
of CVD risk), non-fasting samples are allowed.
Secondly, our study included all risk factors according to 
Dutch guidelines (1), except dietary pattern, which somewhat 
hampers interpretation of our findings. Thirdly, height and 
waist circumference were measured in all participants while 
lying supine, so as to obtain accurate measurements in case 
of deformities of the limbs or restrictions in standing. The 
underscoring of height in our study may partly explain the 
higher proportion of men who were underweight based on 
waist circumference than on BMI. Because no classification 
exists for measurements recorded in the supine position, we 
predicted the standing waist circumference by the correction 
equation of Waninge et al. (29) and classified waist circumfer-
ence according to Lean et al. (30). A limitation of this equation 
is that it is derived from a small and severely affected sample 
with various disorders, however, including CP. Recently, 
Peterson et al. (22) demonstrated that waist-to-hip ratio was 
associated with several markers for dyslipidaemia in adults 
with CP, whereas BMI and waist circumference were not as-
sociated with these markers. Furthermore, it was suggested 
that BMI may be healthy in persons with CP despite the fact 
that they have excessive body fat, because of muscle atrophy 
and diminished bone density. Considering the problems of 
measuring waist circumference and BMI in CP, both were used 
in the multivariable analyses and showed comparable results.
Finally, other parameters (e.g. energy expenditure, sedentary 
time) or longer durations of measurement might deepen our 
understanding of everyday physical activity and its potential 
association with CVD risk. However, our aim was not to 
charac terize habitual physical activity, but to obtain insight into 
the level of everyday physical activity. Therefore, monitoring 
during 2 randomly selected weekdays in both persons with 
CP and the reference sample is considered to be an adequate 
duration to reliably record activities (13, 40). 
Study strengths
Strengths of the study are the extensive objective measure-
ments of CVD risk, unlike in other studies where questionnaires 
are often used, e.g. to assess physical activity. The study fills 
a gap in the literature on biological and lifestyle-related CVD 
risk factors and the clustered CVD risk in adults with CP. 
Conclusion
In this sample of relatively young adults with SBCP the 10-year 
fatal CVD risk was low, but several single CVD risk factors 
were present, of which (pre)hypertensive blood pressure was 
prominent. A higher level of body fat tended to be related to a 
higher 10-year risk, but no relations were demonstrated with 
aerobic fitness or everyday physical activity. 
Further research is warranted with other measures (e.g. 
sedentary time, energy expenditure) and/or a different sample 
(more severely affected persons, older ages) to obtain more 
insight into CVD risk and its relationships with modifiable 
factors. Thus far, the current findings highlight the importance 
of screening for CVD risk factors in SBCP, specifically blood 
pressure and body fatness, and to start preventive strategies 
from young adulthood onwards. 
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